Navigation Links
Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
Date:3/5/2008

Patrick Kenny, Former Senior Clinical Research Associate at Kendle

International, Inc., Joins Catalyst

CORAL GABLES, Fla., March 5 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) today announced the appointment of Patrick Kenny as Director - Corporate Clinical Compliance. In this capacity, Mr. Kenny will be responsible for ensuring the effectiveness and GCP compliance of the CROs, clinical contractors and clinical trial sites involved in the clinical trials conducted under Catalyst's sponsorship.

Commenting on today's announcement, Douglas Winship, Catalyst's Vice President of Regulatory Operations, noted, "Mr. Kenney joins Catalyst at a key point of our corporate development, the initiation of our first series of U.S. clinical trials. He will play a critical role in auditing the performances of our contractors involved in our sponsored clinical trials to assure overall compliance with current Good Clinical Practices guidelines. Pat will also identify opportunities for implementation of improvement programs and training needs, as well as help determine additional resource needs required by the clinical trial sites to facilitate expeditious trial completion. I am confident that his strength in the areas of clinical development planning and coordination, FDA regulations and project leadership will allow him to play an important role at Catalyst as we push forward with the clinical development and ultimate commercialization of CPP-109 for the treatment of both cocaine addiction and methamphetamine addiction."

Mr. Kenny brings to Catalyst 18 years of experience in conducting clinical research programs leading to product approvals in the pharmaceutical industry. Prior
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
2. CATalyst Summit Declared a Success: Its All About the Cat!
3. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
4. Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
5. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
6. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
7. Thomas Farina, Former Pharmaceutical Company District Manager, Charged With Obstruction of Justice
8. ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter 2007 Financial Results
9. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
10. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
11. Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 26, 2014 Bunion Bootie, the newest ... in an early celebration of the early holiday shopping ... offered at the promotional price of $29.95 each (normally ... addition to any automatic discounts applied when buying more ... website for complete details. It’s simple: purchasing more ...
(Date:11/26/2014)... Louisiana Back Institute, leaders of ... minimally invasive spine surgery, announces today the addition ... growing provider network of orthopedic spine surgeons and ... the network’s continuing success providing the most innovative ... who are suffering from orthopedic spine conditions and ...
(Date:11/26/2014)... November 26, 2014 Sonoran Vein ... recently received the Distinguished Preceptorship Award from ... her role in the advancement of nurse practitioners. ... an individual who had made a significant contribution ... The American Association of Nurse Practitioners (AANP) is ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Youngsters who enter puberty ... study suggests. Early puberty was linked with a ... self-image and high anxiety levels, according to the researchers. ... as conflict with family and peers, and having friends ... found. Although the study found an association between ...
(Date:11/26/2014)... -- Teens prescribed anti-anxiety or sleep medications are ... other teens, a new study warns. The ... assessments on teenagers before prescribing these drugs to ... don,t realize the abuse potential," said lead researcher ... Michigan School of Nursing. "These drugs produce highly ...
Breaking Medicine News(10 mins):Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2
... is estimated at around $2.5 trillion per annum, which ... per annum. A radical shift in food consumption pattern ... ,In markets, especially in the developed world, with a ... rapidly increasing. Besides, the emerging health-conscious newer generation globally ...
... Yale Cancer Center is proud to announce the launch of ... Public Radio. Beginning on National Cancer Survivors Day , June ... p.m. on Sunday evenings and feature the latest information on ... Miller, M.D. , ,Cancer Answers is co-hosted by ...
... of therapeutic genes, which will have major implications for ... the 10th Annual Meeting of the American Society of ... gene expression is crucial to the success of gene ... being employed to engineer cells for therapeutic factor production, ...
... gene to diabetes patients using nanoparticles, was presented today at ... Gene Therapy (ASGT) in Seattle. ,Type 1 or ... producing pancreatic -cells. As a result of the loss of ... fine blood vessels and nerve endings leading to debilitating symptoms. ...
... today the start of the EASE (Exhale Airway Stents ... explore an investigational treatment that may offer a ... emphysema. The study focuses on an experimental procedure called ... for trapped air to escape with the goal of ...
... poised to earn the dubious distinction of becoming a country ... better emergency facilities for heart patients could save lives, ... (WHO) reports, India is likely to become the heart attack ... have been spreading like an epidemic and have been affecting ...
Cached Medicine News:Health News:Nutrient-rich Dairy Beverages an Emerging Market 2Health News:Yale Cancer Center Answers: A New Weekly Radio Progam on WNPR 2Health News:New Platform for Regulating Expression of Therapeutic Genes Unveiled 2Health News:Novel Delivery Method of Insulin Gene to Combat Juvenile Diabetes Developed 2Health News:Airway Bypass Treatment for Emphysema - Study 2
(Date:11/26/2014)... 2014  BioScrip ® , Inc. (NASDAQ: BIOS ) ... Executive Officer, will present at the Bank of America Merrill Lynch ... , Date: , , , Wednesday, December 3, 2014 , ... , , , Location: , , , Boca Raton Resort ... Inc. BioScrip, Inc. is a leading national ...
(Date:11/26/2014)... -- Zynerba Pharmaceuticals , Inc., a specialty pharmaceutical ... cannabinoid treatments, today announced that the company will present ... The conference will be held December 2 to 3, ... York . Zynerba,s Chairman and CEO, Armando ... December 2. To listen to a webcast ...
(Date:11/26/2014)... 26, 2014  Aridis Pharmaceuticals, Inc., a biopharmaceutical ... for infectious diseases, announced today the addition of ... key opinion leader in the areas of pneumonia ... Founder and Chief Executive Officer, ... Opal,s extensive experience investigating bacterial toxins and key ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
... WASHINGTON, Aug. 30, 2011 Public Citizen filed a petition ... the FDA should revise its rules that bar generic drug ... drug makers should be allowed to ask the FDA to ... to patients who take their drugs. Reporters developing a story ...
... LAKE FOREST, Ill., Aug. 29, 2011 Hospira, Inc. (NYSE: ... medication delivery company, today announced that it will host an ... 2011. F. Michael Ball, Hospira,s chief executive officer, and several ... event. A streaming audio webcast of the event, ...
Cached Medicine Technology:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: